A research team led by the Medical University of Vienna and the University of Vienna has investigated a possible link between ...

Crofelemer has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency for SBS and MVID. In October 2025, as announced, the company ...

Every night, millions of people work hard to keep our essential services running—treating patients, responding to emergencies ...

This comprehensive review synthesizes a decade of human and animal research to explain how the gut and brain communicate ...

Large language models could transform digestive disorder management, but further RCTs are essential to validate their ...

Renexxion Ireland Limited ('Renexxion'), a private biopharmaceutical company focused on advancing new therapies for patients ...

Learn why the gut–brain connection increases stress and affects IBS symptoms and explore evidence-based treatments like ...

Chronic Intestinal Pseudo-Obstruction (CIPO) and related gastrointestinal motility disorders constitute a group of rare but debilitating conditions that mimic mechanical obstruction despite the ...

With digestive disorders emerging as one of the most common yet under-addressed health concerns in India, Kauvery Hospital, ...